Table 1 Demographic and clinical characteristics by H. pylori eradication groups (n = 69a).

From: High prevalence of clarithromycin resistance and effect on Helicobacter pylori eradication in a population from Santiago, Chile: cohort study and meta-analysis

Variable

Eradication success n = 44

Eradication failure n = 25

p-value

Age, mean (±SD)

46.4 (±14.0)

49.2 (±14.1)

0.429

Gender female

26 (59%)

18 (72%)

0.284

University education

31 (70.5%)

20 (80%)

0.385

Alcohol consumption

13 (29.5%)

4 (16%)

0.256

Tobacco use

11 (25%)

4 (16%)

0.290

Pyrosis (+)

14 (31.8%)

10 (40%)

0.493

Dyspepsia (+)

22 (50%)

13 (52%)

0.873

Epigastralgia (+)

17 (38.6%)

11 (44%)

0.663

Esophagus findings

6 (13.6%)

6 (24%)

0.275

Gastric fundus findings: Congestion (+)

14 (31.8%)

9 (36%)

0.723

Gastric corpus findings: Congestion (+)

20 (45.5%)

10 (40%)

0.660

Antral findings: Congestion and/or nodular gastropathy (+)b

18 (40.9%)

13 (52%)

0.373

Duodenal findings: Erosions and ulcers (+)

12 (27.3%)

6 (24%)

0.766

CLA resistance

5 (11.4%)

13 (52.0%)

<0.001

Phenotype EM

34 (61.8%)

21 (38.2%)

0.235

Phenotype UM

1 (33.3%)

2 (66.7%)

Phenotype IM

9 (81.8%)

2 (18.2%)

  1. aDuring the follow-up four patients dropped their participation in the study.
  2. bNodular gastropathy and congestion were pulled together for analysis. All nodular patients were H. pylori positive by rapid urease test.
Back to article page